Trademark: 87639411
Status Date
Tuesday, May 24, 2022
Registration Number
6720926
Registration Date
Tuesday, May 24, 2022
Filing Date
Tuesday, October 10, 2017
Published for Opposition
Tuesday, April 9, 2019
5 Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of autoimmune, metastatic, hematologic, oncologic, ocular and neurologic diseases, conditions and disorders; Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders associated with misfolded proteins; Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders affecting the central nervous system; Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of amyloidosis, psoriasis, psoriatic arthritis, rheumatoid arthritis, dermatitis, host and graft rejections, Alzheimer's and Parkinson's-disease associated neuropsychiatric disorders, insulin resistance, metabolic syndrome and diabetes
May 24, 2022
Notice Of Registration Confirmation Emailed
May 24, 2022
Registered-Principal Register
Apr 4, 2022
1(B) Basis Deleted; Proceed To Registration
Mar 30, 2022
Notice Of Allowance Cancelled
Mar 30, 2022
Teas Delete 1(B) Basis Received
Dec 14, 2021
Notice Of Approval Of Extension Request E-Mailed
Dec 13, 2021
Sou Extension 5 Granted
Dec 2, 2021
Sou Extension 5 Filed
Dec 13, 2021
Case Assigned To Intent To Use Paralegal
Dec 2, 2021
Teas Extension Received
Jun 4, 2021
Notice Of Approval Of Extension Request E-Mailed
Jun 2, 2021
Sou Extension 4 Granted
Jun 2, 2021
Sou Extension 4 Filed
Jun 2, 2021
Teas Extension Received
Dec 4, 2020
Notice Of Approval Of Extension Request E-Mailed
Dec 2, 2020
Sou Extension 3 Granted
Dec 2, 2020
Sou Extension 3 Filed
Dec 2, 2020
Teas Extension Received
Nov 13, 2020
Notice Of Approval Of Extension Request E-Mailed
Nov 12, 2020
Sou Extension 2 Granted
Jun 4, 2020
Sou Extension 2 Filed
Jul 23, 2020
Petition To Director - Granted
Jul 23, 2020
Assigned To Petition Staff
Jun 18, 2020
Automatic Update Of Assignment Of Ownership
Jun 12, 2020
Teas Petition To Director Received
Jun 4, 2020
Teas Extension Received
Dec 5, 2019
Notice Of Approval Of Extension Request E-Mailed
Dec 3, 2019
Sou Extension 1 Granted
Dec 3, 2019
Sou Extension 1 Filed
Dec 3, 2019
Teas Extension Received
Jun 4, 2019
Noa E-Mailed - Sou Required From Applicant
Apr 9, 2019
Official Gazette Publication Confirmation E-Mailed
Apr 9, 2019
Published For Opposition
Mar 20, 2019
Notification Of Notice Of Publication E-Mailed
Mar 6, 2019
Electronic Record Review Complete
Mar 1, 2019
On Hold - Electronic Record Review Required
Feb 27, 2019
Approved For Pub - Principal Register
Feb 25, 2019
Teas/Email Correspondence Entered
Feb 25, 2019
Correspondence Received In Law Office
Feb 21, 2019
Teas Response To Suspension Inquiry Received
Sep 2, 2018
Notification Of Inquiry As To Suspension E-Mailed
Sep 2, 2018
Inquiry To Suspension E-Mailed
Sep 2, 2018
Suspension Inquiry Written
Aug 9, 2018
Suspension Checked ¿ To Attorney For Action
Aug 9, 2018
Assigned To Lie
Jan 19, 2018
Notification Of Letter Of Suspension E-Mailed
Jan 19, 2018
Letter Of Suspension E-Mailed
Jan 19, 2018
Suspension Letter Written
Jan 19, 2018
Assigned To Examiner
Oct 17, 2017
New Application Office Supplied Data Entered In Tram
Oct 13, 2017
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
